EP4177356
Aðferðir til að meta hættu á þróun veirusjúkdóms með erfðaprófi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
8.8.2019EP published:
8.5.2024EP application number:
22199371.0
EP translation filed:
7.8.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
7.8.2039Expiry date:
7.8.2026Next due date:
31.8.2026
Title in English:
METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TESTLanguage of the patent:
English
Timeline
Today
8.8.2019EP application
8.5.2024EP Publication
7.8.2024Translation submitted
15.9.2024Registration published
7.8.2026Expires
Owner
Name:
PML Screening, LLCAddress:
23 Corporate Plaza, Suite 150, Newport Beach, CA 92660, US
Name:
Université Paris-SaclayAddress:
Bâtiment Breguet 3 Rue Joliot Curie, 91190 Gif sur Yvette, FR
Name:
The Assistance Publique-Hôpitaux de Paris (APHP)Address:
149 rue de Sèvres, 75015 Paris, FR
Name:
The Institut National de la Santé et de la Recherche Médicale (INSERM)Address:
101 rue de Tolbiac, 75654 Paris Cedex 13, FR
Inventor
Name:
HATCHWELL, EliAddress:
New York, NY 10036, US
Name:
EIS, Peggy S.Address:
New York, NY 10036, US
Name:
SMITH, Edward B., IIIAddress:
New York, NY 10036, US
Name:
TAOUFIK, YassineAddress:
75014 Paris, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862716072 PDate:
8.8.2018Country:
US
Number:
201862716183 PDate:
8.8.2018Country:
US
Classification
Categories:
C12Q 1/6883
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 14.8.2024
Expires: 7.8.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.8.2025
Expires: 7.8.2026
Payer: Árnason Faktor ehf.